Myofascial Pain Syndrome: An Update on Clinical Characteristics, Etiopathogenesis, Diagnosis, and Treatment.

Myofascial pain syndrome (MPS) is a chronic muscle pain condition that affects specific regions of the body. It's characterized by trigger points—tight, sensitive spots in muscles that cause pain both at the site and in other areas. Despite being common, MPS is often misdiagnosed because its symptoms overlap with other pain conditions like fibromyalgia and nerve pain. Researchers reviewed the latest evidence on what causes MPS, how to diagnose it, and what treatments work best. The study found that local anesthetic injections have strong evidence for relieving MPS pain. Importantly for acupuncture patients, the research showed that both acupuncture and dry needling demonstrate effectiveness for treating this condition, particularly when compared to placebo treatments. Other therapies with some supporting evidence include magnetic stimulation, ultrasound, laser therapy, shock wave therapy, and manual therapy. Interestingly, commonly prescribed treatments like anti-inflammatory drugs, muscle relaxants, and botulinum toxin showed insufficient or inconclusive evidence. The causes of MPS are complex and include muscle overuse, poor posture, underlying health conditions, and psychological factors. The authors emphasize that successful treatment requires a personalized approach that combines proven therapies based on each patient's specific needs and circumstances. This review highlights that acupuncture is among the evidence-supported options for managing myofascial pain syndrome. If you're considering acupuncture for muscle pain, seek a qualified, licensed acupuncturist with experience treating musculoskeletal conditions.

This narrative review examines current evidence on myofascial pain syndrome (MPS), a chronic regional pain condition characterized by myofascial trigger points causing localized and referred pain. The authors systematically reviewed risk factors, pathogenesis hypotheses, diagnostic approaches, and treatment efficacy. Key findings indicate sufficient evidence supports local anesthetic injections for MPS management. Acupuncture and dry needling demonstrate effectiveness compared to sham or placebo controls, along with magnetic stimulation, ultrasound, laser therapy, extracorporeal shock wave therapy, and manual therapy. NSAIDs, diclofenac, botulinum toxin, and TENS showed insufficient evidence, while muscle relaxants, antidepressants, gabapentin, opioids, and topical agents yielded inconclusive results. The review acknowledges ongoing challenges in MPS pathogenesis understanding, diagnostic standardization, and classification. Clinical takeaway: Evidence supports integrating acupuncture into multimodal, patient-centered MPS management protocols, though high-quality comparative effectiveness research remains needed for optimal treatment sequencing and selection.